Ketaminol

Ketaminol may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ketaminol

Ketamine

Ketamine hydrochloride (a derivative of Ketamine) is reported as an ingredient of Ketaminol in the following countries:

• Austria


• Finland


• Sweden

International Drug Name Search

Popantel

Popantel may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Popantel

Praziquantel

Praziquantel is reported as an ingredient of Popantel in the following countries:

• Australia

Pyrantel

Pyrantel embonate (a derivative of Pyrantel) is reported as an ingredient of Popantel in the following countries:

• Australia

International Drug Name Search

Omeprazole Tablets

Dosage Form: tablet, delayed release
Omeprazole Delayed Release Tablets, 20 mg

Omeprazole Delayed Release Tablets, 20 mg Drug Facts

Active ingredient (in each tablet)

Omeprazole delayed-release tablet, 20 mg

Purpose
Acid reducer

Use

• treats frequent heartburn (occurs 2 or more days a week)


• not intended for immediate relief of heartburn; this drug may take 1 to 4 days for full effect
  

Warning

Allergy alert:  Do not use if you are allergic to omeprazole

Do not use if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools.  These may be signs of a serious condition.  See your doctor.

Ask a doctor before use if you have

• had heartburn over 3 months.  This may be a sign of a more serious condition.


• heartburn with lightheadedness, sweating or dizziness


• chest pain or shoulder pain with shortness or breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness


• frequent chest pain


• frequent wheezing, particularly with heartburn


• unexplained weight loss


• nausea or vomiting


• stomach pain
  

Ask a doctor or pharmacist before use if you are taking

• clopidogrel bisulfate (anti-blood clotting medicine)


• warfarin (blood-thinning medicine)


• prescription antifungal or anti-yeast medicines


• diazepam (anxiety medicine)


• digoxin (heart medicine)


• tacrolimus (immune system medicine)


• atazanavir (medicine for HIV infection)
  

Stop use and ask a doctor if

• your heartburn continues or worsens


• you need to take this product for more than 14 days


• you need to take more than 1 course of treatment every 4 months
  

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.  In case of overdose, get medical help or contact a Poison Control Center right away.

(1-800-2221222)

Directions

• adults 18 years of age and older


• this product is to be used once a day (every 24 hours), every day for 14 days


• it may take 1 to 4 days for full effect, although some people get complete relief of symptoms within 24 hours

14-Day Course of Treatment

• swallow 1 tablet with a glass of water before eating in the morning


• take every day for 14 days


• do not take more than 1 tablet a day


• do not chew or crush the tablets


• do not crush tablets in food


• do not use for more than 14 days unless directed by your doctor

Repeated 14-Day Courses (if needed)

• you may repeat a 14-day course every 4 months


• do not take for more than 14 days or more often than every 4 months unless directed by a doctor

• children under 18 years of age:  ask a doctor
  

Other information

• read the directions, warnings, and package insert before use


• keep the carton and package insert.  They contain important information.


• store at 20-25°C (68-77°F)


• keep product out of high heat and humidity


• protect product from moisture
  

Inactive ingredients carnauba wax, ferric oxide red, ferric oxide yellow, hypromellose, hypromellose acetate succinate, lactose monohydrate, monoethanolamine, propylene glycol, sodium lauryl sulfate, sodium starch glycolate, sodium stearate, sodium stearyl fumarate, talc, titanium dioxide, triethyl citrate

Questions or comments?

1-800-719-9260

Inner Carton Label

Treats Frequent Heartburn!
Occurring 2 or More Days a Week

Omeprazole

delayed release tablets 20 mg

acid reducer

14 TABLETS
One 14-day course of treatment

Blister Label

Omeprazole DR Tablets

20 mg

Acid reducer

Push tablet through foil.

Dexcel Ltd.

1 Dexcel St.  Or Akiva

30600, Israel


Do not chew or crush tablets


Do not crush tablets in food

Bottle Label

NOT FOR RESALE


Treats Frequent Heartburn!

Occurring 2 or More Days a Week


Omeprazole Delayed

Release Tablets 20 mg


Acid Reducer


14 Tablets

One 14-day course of treatment


DO NOT USE IF PRINTED SEAL UNDER CAP IS BROKEN OR MISSING


Manufactured by:

Dexcel® Ltd.

1 Dexcel St., Or Akiva

30600, Israel


Made in Israel

Patient Package Insert

Omeprazole Delayed Release Tablets 20 mg


Acid Reducer


Please read all of this package insert before taking Omeprazole Delayed Release Tablets 20 mg.  Save this to read, as you need.


How Omeperazole Delayed Release Tablets 20 mg Work For Your Frequent Heartburn


Omeprazole Delayed Release Tablets 20 mg work differently from other heartburn products, such as antacids and other acid reducers.  Omeprazole Delayed Release Tablets 20 mg stop acid production at the source - the acid pump that produces stomach acid.  Omeprazole Delayed Release Tablets 20 mg are to be used once a day (every 24 hours), every day for 14 days.


What to Expect When Using Omeprazole Delayed Release Tablets 20 mg


Omeprazole Delayed Release Tablets 20 mg are a different type of medicine from antacids and other acid reducers.  Omeprazole Delayed Release Tablets 20 mg may take 1 to 4 days for full effect, although some people get complete relief of symptoms within 24 hours.  Make sure you take the entire 14 days of dosing to treat your frequent heartburn.


Safety Record


For years, doctors have prescribed omeprazole to treat acid-related conditions in millions of people safely.


Who Should Take Omeprazole Delayed Release Tablets 20 mg


This product is for adults (18 years and older) with frequent heartburn - when you have heartburn 2 or more days a week.

• Omeprazole Delayed Release Tablets 20 mg are not intended for those who have heartburn infrequently, one episode of heartburn a week or less, or for those who want immediate relief or heartburn.

How to Take Omeprazole Delayed Release Tablets 20 mg


14-Day Course of Treatment

• Swallow 1 tablet with a glass of water before eating in the morning.


• Take every day for 14 days.


• Do not take more than 1 tablet a day


• Do not chew or crush the tablets.


• Do not crush tablets in food.


• Do not use for more than 14 days unless directed by your doctor.

It is important not to chew or crush these tablets, or crush the tablets in food.  This decreases how well Omeprazole Delayed Release Tablets 20 mg work.


When to Take Omeprazole Delayed Release Tablets 20 mg Again


You may repeat a 14-day course of therapy every 4 months.


When to Talk to Your Doctor


Do not take for more than 14 days or more often than every 4 months unless directed by a doctor.


Warnings and When to Ask Your Doctor


Allergy alert:  Do not use if you are allergic to omeprazole


Do not use if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools.  These may be signs of a serious condition.  See your doctor.


Ask a doctor before use if you have

• had heartburn over 3 months.  This may be a sign of a more serious condition


• heartburn with lightheadedness, sweating or dizziness


• chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness


• frequent chest pain


• frequent wheezing, particularly with heartburn


• unexplained weight loss


• nausea or vomiting


• stomach pain

Ask a doctor or pharmacist before use if you are taking

• clopidogrel bisulfate (anti-blood clotting medicine)


• warfarin (blood-thinning medicine)


• prescription antifungal or anti-yeast medicines


• diazepam (anxiety medicine)


• digoxin (heart medicine)


• tacrolimus (immune system medicine)


• atazanavir (medicine for HIV infection)

Stop use and ask a doctor if

• your heartburn continues or worsens


• you need to take this product for more than 14 days


• you need to take more than 1 course of treatment every 4 months

If pregnant or breast-feeding,

ask a health professional before use.


Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.  (1-800-222-1222)


Tips for Managing Heartburn

• Do not lie flat or bend over soon after eating.


• Do not eat late at night or just before bedtime.


• Certain foods or drinks are more likely to cause heartburn, such as rich, spicy, fatty and fried foods, chocolate, caffeine, alcohol and even some fruits and vegetables.


• Eat slowly and do not eat big meals.


• If you are overweight, lose weight.


• If you smoke, quit smoking.


• Raise the head of your bed.


• Wear loose-fitting clothing around your stomach.

How are Omeprazole Delayed Release Tablets 20 mg Sold


Omeprazole Delayed Release Tablets 20 mg are available in 14 tablet, 28 tablet and 42 tablet sizes.  These sizes contain one, two and three 14-day courses of treatment, respectively.  Do not use for more than 14 days in a row unless directed by your doctor.  For the 28 count (two 14-day courses) and the 42 count (three 14-day courses), you may repeat a 14-day course every 4 months.


For Questions or Comments About Omeprazole Delayed Release Tablets 20 mg


Call 1-800-719-9260


Made in Israel


Manufactured by:

DEXCEL® LTD.

Southern Industrial Zone

Or Akiva 30600, Israel

Bulk 7-Count Blister Pack Carton Label

70 Tablets


OMEPRAZOLE DR TABLETS 20 MG OTC

Acid reducer


FOR REPACKAGING ONLY


Manufactured by:  DEXCEL® LTD.

Southern Industrial Zone, Or Akiva 30600, Israel

• Store at 15° - 25°C (59° - 77°F)


• Keep product out of high heat and humidity


• Protect product from moisture

OMEPRAZOLE   DELAYED RELEASE omeprazole  tablet, delayed release

Product Information Product Type HUMAN OTC DRUG NDC Product Code (Source) 64861-303 Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Omeprazole (Omeprazole) Omeprazole 20 mg

Inactive Ingredients Ingredient Name Strength Carnauba Wax   Ferric Oxide Red   Ferric Oxide Yellow   Hypromellose   Hypromellose Acetate Succinate 12070923 (3 MM2/S)   Lactose Monohydrate   Ethanolamine   Propylene Glycol   Sodium Lauryl Sulfate   Sodium Starch Glycolate Type A Potato   Sodium Stearate   Sodium Stearyl Fumarate   Talc   Titanium Dioxide   Triethyl Citrate

Product Characteristics Color brown (brownish) Score no score Shape OVAL (capsule-shaped) Size 13mm Flavor Imprint Code 20 Contains

Packaging # NDC Package Description Multilevel Packaging 1 64861-303-01 14 TABLET In 1 BOTTLE, PLASTIC None 2 64861-303-02 10 BLISTER PACK In 1 CARTON contains a BLISTER PACK 2 7 TABLET In 1 BLISTER PACK This package is contained within the CARTON (64861-303-02) 3 64861-303-03 2 BLISTER PACK In 1 CARTON contains a BLISTER PACK 3 7 TABLET In 1 BLISTER PACK This package is contained within the CARTON (64861-303-03)

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
NDA	NDA022032	03/01/2008

Labeler - Dexcel Ltd. (600534200)

Establishment
Name	Address	ID/FEI	Operations
Dexcel Ltd.		600534200	analysis, label, manufacture, pack

Revised: 04/2010Dexcel Ltd.

More Omeprazole Tablets resources

• Omeprazole Tablets Side Effects (in more detail)
• Omeprazole Tablets Dosage
• Omeprazole Tablets Use in Pregnancy & Breastfeeding
• Drug Images
• Omeprazole Tablets Drug Interactions
• Omeprazole Tablets Support Group
• 46 Reviews for Omeprazoles - Add your own review/rating

Compare Omeprazole Tablets with other medications

• Barrett's Esophagus
• Duodenal Ulcer
• Erosive Esophagitis
• GERD
• Helicobacter Pylori Infection
• Indigestion
• Multiple Endocrine Adenomas
• Stomach Ulcer
• Systemic Mastocytosis
• Zollinger-Ellison Syndrome

Mitozantrone Ebewe

Mitozantrone Ebewe may be available in the countries listed below.

Ingredient matches for Mitozantrone Ebewe

Mitoxantrone

Mitoxantrone dihydrochloride (a derivative of Mitoxantrone) is reported as an ingredient of Mitozantrone Ebewe in the following countries:

• New Zealand

International Drug Name Search

Atossa

Atossa may be available in the countries listed below.

Ingredient matches for Atossa

Ondansetron

Ondansetron hydrochloride (a derivative of Ondansetron) is reported as an ingredient of Atossa in the following countries:

• Poland

International Drug Name Search

Recur

Recur may be available in the countries listed below.

Ingredient matches for Recur

Finasteride

Finasteride is reported as an ingredient of Recur in the following countries:

• Bangladesh

International Drug Name Search

Sedamun

Sedamun may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Sedamun

Xylazine

Xylazine hydrochloride (a derivative of Xylazine) is reported as an ingredient of Sedamun in the following countries:

• Netherlands

International Drug Name Search

Acriflavinium Chloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

R02AA13

CAS registry number (Chemical Abstracts Service)

0008063-24-9

Chemical Formula

C14-H15-Cl2-N3

Molecular Weight

296

Therapeutic Categories

Antiseptic

Disinfectant

Chemical Name

Acridinium, 3,6-diamino-10-methyl-, chloride, monohydrochloride, mixt. with 3,6-acridinediamine monohydrochloride

Foreign Names

• Acriflavinii Chloridum (Latin)
• Acriflavinium chlorid (German)
• Chlorure d'Acriflavinium (French)
• Cloruro de acriflavinio (Spanish)

Generic Names

• Acriflavinium (chlorure d') (OS: DCF)
• Acriflavino cloruro (OS: DCIT)
• Acriflavine Hydrochloride (IS)
• Flavacridinum (IS: USSRP)
• Neutroflavine (IS)
• Panflavin (IS)
• Trypaflavin (IS)
• Xanthacridinum (IS)
• Acriflavinii chloridum (PH: Ph. Helv. 8)
• Acriflavinium Chloride (PH: BP 2007)
• Acriflavinium Monochloride (PH: Ph. Eur. 5)
• Acriflaviniumchlorid (PH: Ph. Helv. 8)
• Acriflaviniummonochloride (PH: Ph. Eur. 5)

Brand Name

• Chromargon (Acriflavinium Chloride and Oxyquinoline)
  Richard, France

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Oximetazolina

Oximetazolina may be available in the countries listed below.

Ingredient matches for Oximetazolina

Oxymetazoline

Oximetazolina (DCIT) is known as Oxymetazoline in the US.

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Vanaurus

Vanaurus may be available in the countries listed below.

Ingredient matches for Vanaurus

Vancomycin

Vancomycin is reported as an ingredient of Vanaurus in the following countries:

• Peru

International Drug Name Search

Fuset

Fuset may be available in the countries listed below.

Ingredient matches for Fuset

Buserelin

Buserelin acetate (a derivative of Buserelin) is reported as an ingredient of Fuset in the following countries:

• Japan

International Drug Name Search

Amantadin AL

Amantadin AL may be available in the countries listed below.

Ingredient matches for Amantadin AL

Amantadine

Amantadine sulfate (a derivative of Amantadine) is reported as an ingredient of Amantadin AL in the following countries:

• Germany

International Drug Name Search

Iodio Ramini

Iodio Ramini may be available in the countries listed below.

Ingredient matches for Iodio Ramini

Iodine

Iodine is reported as an ingredient of Iodio Ramini in the following countries:

• Italy

Potassium Iodide

Potassium Iodide is reported as an ingredient of Iodio Ramini in the following countries:

• Italy

International Drug Name Search

Nitro Mack Retard

Nitro Mack Retard may be available in the countries listed below.

Ingredient matches for Nitro Mack Retard

Nitroglycerin

Nitroglycerin is reported as an ingredient of Nitro Mack Retard in the following countries:

• Bahrain


• Cyprus


• Egypt


• Jordan


• Kuwait


• Lebanon


• Oman


• Qatar


• Saudi Arabia


• United Arab Emirates

International Drug Name Search